| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |